Healthy Extracts (HYEX) EBITDA Margin Growth (3y) (2018 - 2026)
Healthy Extracts (HYEX) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | 21,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,105.00 |
| Dec 31, 2025 | 821.00 |
| Sep 30, 2025 | -3,922.00 |
| Jun 30, 2025 | 11,982.00 |
| Mar 31, 2025 | -341.00 |
| Dec 31, 2024 | 6,122.00 |
| Sep 30, 2024 | 5,413.00 |
| Jun 30, 2024 | 10,313.00 |
| Mar 31, 2024 | 33,546.00 |
| Dec 31, 2023 | 117,452.00 |
| Sep 30, 2023 | -1,799.00 |
| Jun 30, 2023 | -698.00 |
| Mar 31, 2023 | 118,186.00 |
| Dec 31, 2022 | 30,924.00 |
| Sep 30, 2022 | -786.00 |
| Jun 30, 2022 | -5,844.00 |
| Mar 31, 2022 | 19,425.00 |
| Dec 31, 2021 | 425,393.00 |
| Sep 30, 2021 | 58,886.00 |
| Jun 30, 2021 | 34,837.00 |